Novogen (ASX: NRT) - Picking up where Genentech left off Stuart Roberts Pitt Street Research and NDF Research
SUDA - Faster, safer delivery for ex-blockbusters Stuart Roberts Pitt Street Research and NDF Research
Cynata - The Swiss Army Knife of cellular remedies Stuart Roberts Pitt Street Research and NDF Research
Dimerix's Phase 2 success for DMX-200 - an important potential new treatment option for kidney disease Stuart Roberts Pitt Street Research and NDF Research
ResApp Health - First major clinical study of ResAppDx reports important data Stuart Roberts Pitt Street Research and NDF Research
Optiscan Imaging - The phoenix rises from the ashes Stuart Roberts Pitt Street Research and NDF Research
Alcidion - Making hospitals smarter with Clinical Decision Support Stuart Roberts Pitt Street Research and NDF Research
